Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
2 hedge funds and large institutions have $1.31M invested in Abeona Therapeutics Inc Warrant in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
5% more capital invested
Capital invested by funds: $1.24M → $1.31M (+$68K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $1.07M | – | – | – |
|
|
SFM
2
Soros Fund Management
New York
| $238K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$1K | -1,310 | Closed |
|
ABEOW Hedge Fund Activity: Q2 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q2 2016, worth a combined $1.31M — up 5.5% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ABEOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 2 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q2 2016, down from 3 in Q1 2016.
- Funds reported $1.31M of Abeona Therapeutics Inc Warrant stock for Q2 2016, up 5.5% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q2 2016 and 1 closed out, a net change of -1 holder.
- The largest Abeona Therapeutics Inc Warrant seller in Q2 2016 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2016.